BioSpace News Archive

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, has prioritised the recommencement of the process of scaling up the manufacturing of its lead product candidate eftilagimod alpha (“efti” or “IMP321”). This follows the very encouraging interim results Immutep announced from its efti clinical trials at SITC (10 Nove

Covanos, Inc., a privately-held medical technology company that is developing C-HEART, a PC-based software product that uses proprietary advances in computational fluid dynamics to rapidly and non-invasively diagnose the severity of coronary artery blockages, today announced the appointment of Gil Amelio, Ph.D. to the Covanos Board of Directors.

Thermo Fisher Scientific, the world leader in serving science, today announced the construction of a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif.

BRAINBox Solutions today announced it is beginning enrollment in its pivotal clinical trial, HeadSMART II (Head injury Serum markers and Multi-modalities for Assessing Response to Trauma), of the company’s concussion diagnostic and prognostic test, BRAINBox TBI.

The Buck Institute for Research on Aging is pleased to announce the appointment of Malene Hansen PhD to the position of Professor and Chief Scientific Officer.

New Hampshire and the City of Chicago, among others, are using the Salesforce Platform to more safely and efficiently manage their vaccine programs at scale

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the first session of its virtual investor mini-series themed “Delivering on the Promise of Synthetic Biology.”

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, announced today that the first patient has been treated in the Company’s first-in-human Early Feasibility Study (EFS) evaluating the HEMOPURIFIER® in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced that the Company will present at the annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 7:30 a.m. ET.

Vonco Products LLC, an industry-leader in the contract manufacturing of liquid-tight medical devices and fluid bags, biohazard transport bags, and infection prevention PPE and equipment covers announced today that the company received certification of their Quality Management System to the requirements of ISO 13485:2016. This